Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation (CADENCE 215)

This study has been terminated.
(Enrollment Difficulty)
Information provided by (Responsible Party):
Otsuka Pharmaceutical Development & Commercialization, Inc. Identifier:
First received: November 29, 2011
Last updated: December 11, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)